Randomized phase II trial of a first-in-human cancer cell lysate vaccine in patients with thoracic malignancies.
Transl Lung Cancer Res
; 10(7): 3079-3092, 2021 Jul.
Article
in En
| MEDLINE
| ID: mdl-34430349
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
Transl Lung Cancer Res
Year:
2021
Document type:
Article
Affiliation country:
United States
Country of publication:
China